万基遗传(MYGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MYGN 万基遗传

交易中 03-31 14:33:15 EDT

4.46

+0.10

+2.18%

最高4.53	最低4.36	成交量47.92万
今开4.38	昨收4.36	日振幅3.90%
总市值4.15亿	流通市值3.82亿	总股本9,321万
成交额212.05万	换手率0.56%	流通股本8,572万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MYGN","market":"US","secType":"STK","nameCN":"万基遗传","latestPrice":4.455,"timestamp":1774981988984,"preClose":4.36,"halted":0,"volume":479246,"delay":0,"changeRate":0.021788990825688016,"floatShares":85724024,"shares":93213722,"eps":-3.95,"marketStatus":"交易中","change":0.095,"latestTime":"03-31 14:33:15 EDT","open":4.38,"high":4.525,"low":4.355,"amount":2120454.7904424,"amplitude":0.038991,"askPrice":4.46,"askSize":552,"bidPrice":4.45,"bidSize":1402,"shortable":3,"etf":0,"ttmEps":-3.95,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774987200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.36,"preHourTrading":{"tag":"盘前","latestPrice":4.24,"preClose":4.36,"latestTime":"07:00 EDT","volume":911,"amount":3862.6400000000003,"timestamp":1774954803002,"change":-0.12,"changeRate":-0.027523,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.25,"preClose":4.36,"latestTime":"19:43 EDT","volume":41323,"amount":180060.1,"timestamp":1774914222756,"change":-0.11,"changeRate":-0.025229,"amplitude":0.026376},"volumeRatio":0.428494,"impliedVol":0.7591,"impliedVolPercentile":0.753},"requestUrl":"/m/hq/s/MYGN","defaultTab":"news","newsList":[{"id":"1197429393","title":"万基遗传Mychoice Cdx检测获FDA批准 成为卵巢癌药物Zejula伴随诊断方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1197429393","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197429393?lang=zh_cn&edition=full","pubTime":"2026-03-18 04:06","pubTimestamp":1773777976,"startTime":"0","endTime":"0","summary":"万基遗传（Myriad Genetics）宣布，其Mychoice Cdx检测正式获得美国食品药品监督管理局（FDA）批准，将作为Zejula（尼拉帕利）的伴随诊断工具，用于卵巢癌患者的治疗方案指导。这一批准标志着该检测在精准医疗领域应用的重要突破，将为临床医生提供更精准的用药依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616533961","title":"巨头入局！Myriad Genetics正式杀入MRD赛道，乳腺癌检测三月开售","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533961","media":"GLOIVD","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616533961?lang=zh_cn&edition=full","pubTime":"2026-03-04 08:00","pubTimestamp":1772582416,"startTime":"0","endTime":"0","summary":"2026年2月底，Myriad Genetics在发布其2025年第四季度及全年财报的同时，宣布了一个可能改变行业格局的决定：其名为“Precise”的MRD检测产品，将于3月初正式启动商业化销售，首发适应症为乳腺癌。新战役对于国内IVD从业者而言，Myriad Genetics是一个既熟悉又颇具分量的名字。肿瘤谱分析业务收入全年下降3%，药物基因组学业务更是因头部支付方UnitedHealthcare停止覆盖其GeneSight检测，而遭受重创，全年收入骤降15%。据披露，Precise MRD assay是一种“肿瘤知情”且基于“全基因组测序”的检测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603040812359542db8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603040812359542db8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MYGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616914533","title":"万基遗传盘中异动 下午盘急速拉升5.19%报5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616914533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616914533?lang=zh_cn&edition=full","pubTime":"2026-03-04 02:45","pubTimestamp":1772563533,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日02时45分，万基遗传股票出现波动，股价急速上涨5.19%。截至发稿，该股报5.27美元/股，成交量79.897万股，换手率0.85%，振幅9.78%。万基遗传股票所在的生命科学行业中，整体跌幅为0.71%。其相关个股中，Insight Molecular Diagnostics Inc.、Genedx Holdings Corp.、万基遗传涨幅较大，Xwell, Inc.、Ispecimen Inc.、Genedx Holdings Corp.较为活跃，换手率分别为33.19%、2.81%、2.00%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Xwell, Inc.、Genedx Holdings Corp.，振幅分别为32.85%、17.06%、16.36%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030402453397a7e44e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030402453397a7e44e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603026575","title":"万基遗传盘中异动 早盘急速拉升5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603026575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603026575?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:33","pubTimestamp":1768228388,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时33分，万基遗传股票出现异动，股价大幅上涨5.78%。截至发稿，该股报6.96美元/股，成交量8.3208万股，换手率0.09%，振幅5.09%。万基遗传股票所在的生命科学行业中，整体涨幅为0.37%。其相关个股中，Biodesix, Inc.、万基遗传、Twist Bioscience Corporation涨幅较大，Biodesix, Inc.、Ispecimen Inc.、Genedx Holdings Corp.较为活跃，换手率分别为147.18%、0.37%、0.31%，振幅较大的相关个股有万基遗传、Exagen Inc.、纽勤，振幅分别为6.00%、4.89%、4.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222330997a175fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011222330997a175fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601126458","title":"万基遗传盘中异动 早盘股价大涨5.05%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601126458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601126458?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:49","pubTimestamp":1767710990,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日22时49分，万基遗传股票出现波动，股价快速拉升5.05%。截至发稿，该股报6.45美元/股，成交量3.9163万股，换手率0.04%，振幅5.54%。万基遗传股票所在的生命科学行业中，整体涨幅为1.05%。其相关个股中，Mainz Biomed N.V.、Guardant Health, Inc.、Twist Bioscience Corporation涨幅较大，Mainz Biomed N.V.、Ispecimen Inc.、精密科学较为活跃，换手率分别为4.97%、2.08%、0.57%，振幅较大的相关个股有Exagen Inc.、Mainz Biomed N.V.、Caredx, Inc.，振幅分别为13.53%、10.24%、8.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106224950a6fadc39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106224950a6fadc39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593495232","title":"万基遗传盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593495232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593495232?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:27","pubTimestamp":1766417237,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日23时27分，万基遗传股票出现异动，股价快速上涨5.04%。截至发稿，该股报6.88美元/股，成交量14.5726万股，换手率0.16%，振幅5.42%。机构评级方面，在所有13家参与评级的机构中，23%的券商给予买入建议，54%的券商给予持有建议，23%的券商给予卖出建议。万基遗传股票所在的生命科学行业中，整体涨幅为0.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222232717953b84ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222232717953b84ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586475552","title":"万基遗传盘中异动 下午盘股价大涨5.26%报7.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586475552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586475552?lang=zh_cn&edition=full","pubTime":"2025-11-25 04:23","pubTimestamp":1764015818,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日04时23分，万基遗传股票出现波动，股价大幅上涨5.26%。截至发稿，该股报7.77美元/股，成交量61.6461万股，换手率0.66%，振幅6.03%。机构评级方面，在所有14家参与评级的机构中，21%的券商给予买入建议，57%的券商给予持有建议，22%的券商给予卖出建议。万基遗传股票所在的生命科学行业中，整体涨幅为1.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112504233895180d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112504233895180d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183574199","title":"万基遗传第三季度每股亏损0.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183574199","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183574199?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:31","pubTimestamp":1763569907,"startTime":"0","endTime":"0","summary":"11月3日 - 万基遗传第三季度毛利率为69.9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137052041","title":"异动解读 | 财报不及预期，万基遗传盘中大跌9.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137052041","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137052041?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:50","pubTimestamp":1762267842,"startTime":"0","endTime":"0","summary":"基因检测公司万基遗传今日盘中大跌9.29%，延续了此前的下跌趋势。这一显著跌幅主要源于公司最新发布的2025年第三季度财务业绩不及市场预期。尽管公司报告第三季度毛利率达到69.9%，但持续的亏损状况引发了投资者的担忧。尽管财务业绩不佳，万基遗传仍然重申了其2025年的财务指引，显示公司管理层对未来业务发展保持信心。然而，市场对此反应冷淡，投资者似乎更关注当前的财务表现而非未来预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162589806","title":"异动解读 | 万基遗传盘前大跌6.48%，第三季度业绩不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1162589806","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162589806?lang=zh_cn&edition=full","pubTime":"2025-11-04 17:54","pubTimestamp":1762250063,"startTime":"0","endTime":"0","summary":"基因检测公司万基遗传今日盘前股价大跌6.48%，延续了昨日盘后下跌的趋势。这一显著跌幅主要源于公司最新发布的2025年第三季度财务业绩不及市场预期。尽管公司报告第三季度毛利率达到69.9%，但持续的亏损状况引发了投资者的担忧。尽管财务业绩不佳，万基遗传仍然重申了其2025年的财务指引，显示公司管理层对未来业务发展保持信心。分析人士指出，公司需要在未来几个季度中展现出明显的业绩改善，才能重新赢得投资者的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181460981","title":"异动解读 | 万基遗传发布第三季度业绩不佳，盘后股价暴跌7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181460981","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181460981?lang=zh_cn&edition=full","pubTime":"2025-11-04 06:02","pubTimestamp":1762207351,"startTime":"0","endTime":"0","summary":"基因检测公司万基遗传周一盘后股价大幅下挫，截至发稿时跌幅达7.09%。这一显著跌幅紧随公司发布2025年第三季度财务业绩之后，投资者似乎对公司的表现感到失望。根据万基遗传发布的财报显示，公司第三季度每股亏损0.29美元，这一数字可能远低于分析师的预期。尽管公司报告第三季度毛利率达到69.9%，但亏损状况仍然引发了市场的担忧。尽管财务业绩不佳，万基遗传仍然重申了其2025年的财务指引，这表明公司管理层对未来业务发展保持信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110060266","title":"万基遗传第三季度每股亏损0.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110060266","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110060266?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:24","pubTimestamp":1762205098,"startTime":"0","endTime":"0","summary":"11月3日 - 万基遗传第三季度毛利率为69.9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169850662","title":"万基遗传与Sophia Genetics合作开发创新液体活检伴随诊断产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1169850662","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169850662?lang=zh_cn&edition=full","pubTime":"2025-09-23 20:03","pubTimestamp":1758628996,"startTime":"0","endTime":"0","summary":"万基遗传与Sophia Genetics将合作开发创新的液体活检伴随诊断解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518208004","title":"万基遗传盘中异动 大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208004?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:41","pubTimestamp":1741624873,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时41分，万基遗传股票出现异动，股价快速下跌5.01%。截至发稿，该股报9.67美元/股，成交量34.2039万股，换手率0.37%，振幅5.89%。万基遗传股票所在的生命科学行业中，整体跌幅为0.24%。其相关个股中，Atlantic International Corp.、安奈特保险、恩佐生化涨幅较大，Ispecimen Inc.、安奈特保险、Mainz Biomed N.V.较为活跃，换手率分别为8.55%、4.52%、3.55%，振幅较大的相关个股有Xwell, Inc.、安奈特保险、Inotiv, Inc.，振幅分别为34.62%、27.57%、20.23%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004113abf34170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004113abf34170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MYGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517601768","title":"Piper Sandler：维持Myriad Genetics(MYGN.US)评级，由中性调整至中性评级, 目标价由14.00美元调整至11.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517601768","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517601768?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:02","pubTimestamp":1741107763,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持Myriad Genetics(MYGN.US)评级，由中性调整至中性评级, 目标价由14.00美元调整至11.50美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05010248524009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516635066","title":"B of A Securities：维持Myriad Genetics(MYGN.US)评级，由低于大市调整至低于大市评级, 目标价由13.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635066","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516635066?lang=zh_cn&edition=full","pubTime":"2025-03-03 21:20","pubTimestamp":1741008035,"startTime":"0","endTime":"0","summary":"B of A Securities：维持Myriad Genetics(MYGN.US)评级，由低于大市调整至低于大市评级, 目标价由13.00美元调整至11.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/03212048493049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516303875","title":"万基遗传盘中异动 股价大跌5.02%报10.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516303875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516303875?lang=zh_cn&edition=full","pubTime":"2025-03-01 02:58","pubTimestamp":1740769099,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日02时58分，万基遗传股票出现异动，股价大幅下挫5.02%。截至发稿，该股报10.51美元/股，成交量59.329万股，换手率0.65%，振幅6.42%。万基遗传股票所在的生命科学行业中，整体涨幅为0.19%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Opko健康、Oncocyte Corporation涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Prophase Labs, Inc.较为活跃，换手率分别为8.25%、6.54%、6.19%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Genedx Holdings Corp C/Wts 22/07/2026 、Bioaffinity Technologies, Inc.，振幅分别为51.05%、23.17%、18.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301025819a2583f8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301025819a2583f8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516329379","title":"万基遗传2024财年实现净利润-1.27亿美元，同比增加51.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516329379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516329379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758449,"startTime":"0","endTime":"0","summary":"3月1日，万基遗传公布财报，公告显示公司2024财年净利润为-1.27亿美元，同比增加51.71%；其中营业收入为8.38亿美元，同比增加11.29%，每股基本收益为-1.41美元。从资产负债表来看，万基遗传总负债3.27亿美元，其中短期债务12.80百万美元，资产负债比为3.15，流动比率为1.82。机构评级：截至2025年3月1日，当前有15家机构对万基遗传目标价做出预测，其中目标均价为17.33美元，其中最低目标价为8.00美元，最高目标价为29.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000108abe0ffb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000108abe0ffb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514012182","title":"雷蒙德詹姆斯公司：重申Myriad Genetics(MYGN.US)评级，由优于大市调整至优于大市评级, 目标价由27.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012182","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514012182?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:21","pubTimestamp":1740504092,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司：重申Myriad Genetics(MYGN.US)评级，由优于大市调整至优于大市评级, 目标价由27.00美元调整至19.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26012148385987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015414","title":"瑞银：维持Myriad Genetics(MYGN.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015414","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015414?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:26","pubTimestamp":1740497169,"startTime":"0","endTime":"0","summary":"瑞银：维持Myriad Genetics(MYGN.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至16.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25232648384059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MYGN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.myriad.com","stockEarnings":[{"period":"1week","weight":-0.0644},{"period":"1month","weight":-0.0542},{"period":"3month","weight":-0.2934},{"period":"6month","weight":-0.436},{"period":"1year","weight":-0.509},{"period":"ytd","weight":-0.2911}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0787},{"period":"3month","weight":-0.0801},{"period":"6month","weight":-0.0546},{"period":"1year","weight":0.1373},{"period":"ytd","weight":-0.0732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Myriad Genetics, Inc.是特拉华州的一家公司。该公司是一家领先的基因检测和精准医疗公司，致力于促进所有人的健康和福祉。该公司提供的洞察力帮助人们控制自己的健康，并使医疗保健提供者能够更好地发现、治疗和预防疾病。该公司开发并提供测试，帮助评估疾病或疾病进展的风险，并指导跨医学专业的治疗决策，在这些专业中，基因洞察力可以显著改善患者护理并降低医疗成本。","yearOnYearQuotes":[{"month":1,"riseRate":0.548387,"avgChangeRate":0.064948},{"month":2,"riseRate":0.258065,"avgChangeRate":-0.012645},{"month":3,"riseRate":0.483871,"avgChangeRate":0.014661},{"month":4,"riseRate":0.433333,"avgChangeRate":-0.003162},{"month":5,"riseRate":0.533333,"avgChangeRate":0.008599},{"month":6,"riseRate":0.433333,"avgChangeRate":0.006432},{"month":7,"riseRate":0.533333,"avgChangeRate":0.012647},{"month":8,"riseRate":0.633333,"avgChangeRate":0.015846},{"month":9,"riseRate":0.5,"avgChangeRate":0.04385},{"month":10,"riseRate":0.566667,"avgChangeRate":0.044634},{"month":11,"riseRate":0.516129,"avgChangeRate":0.02599},{"month":12,"riseRate":0.483871,"avgChangeRate":-0.004191}],"exchange":"NASDAQ","name":"万基遗传","nameEN":"Myriad Genetics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万基遗传(MYGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万基遗传(MYGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万基遗传,MYGN,万基遗传股票,万基遗传股票老虎,万基遗传股票老虎国际,万基遗传行情,万基遗传股票行情,万基遗传股价,万基遗传股市,万基遗传股票价格,万基遗传股票交易,万基遗传股票购买,万基遗传股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万基遗传(MYGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万基遗传(MYGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}